NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









APITBIO, Inc.

APITBIO, Inc.

Private
SeoulHealthcare & Life Scienceshttps://apitbio.com/

Last Round

Strategic

Dec 6, 2024

Total Funding Raised

$17.17M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

APITBIO, Inc. is a biotechnology company that develops antibody-based therapeutics for cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

antibody therapeuticsmonoclonal antibodybispecific antibodydrug discoverybiotechoncologyCAR-Tantibody discoverybiologicssynthetic antibody librarydrug pipelineL1CAMCD171biopharmaout-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

APITBIO, Inc. Comparables

Compare APITBIO, Inc. with similar companies based on industry and business-model similarity.

APITBIO, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Y-Biologics
80%
Phanes Therapeutics
79%
Aimed Bio Inc.
78%

APITBIO, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 6, 2024
GrantApr 30, 2024
Series AFeb 8, 2021
SeedJul 1, 2019
AngelMar 1, 2019

APITBIO, Inc. Investors

Notable investors and investment history

APITBIO, Inc. investors
InvestorRounds
KDB Capital CorpSeries A
Shinhan Venture InvestmentSeries A, Seed
UTC InvestmentSeries A
Mirae Equity PartnersSeries A
KB SecuritiesSeries A
Hyundai Technology InvestmentSeries A
Kolon InvestmentSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 53% MoM.

  • May 19, 2026

    Monthly visitors increased 634% MoM, from 237 to 1.7K.

APITBIO, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

APITBIO, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about APITBIO, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2018
Last FundingDec 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.